AnnexinA5 renders dead tumor cells immunogenic—implications for multimodal cancer therapies

Hyperthermia in combination with X-irradiation induces inflammatory forms of cell death

(2009) Petra Schildkopf et al.   AUTOIMMUNITY

Recognition of Live Phosphatidylserine-Labeled Tumor Cells by Dendritic Cells: A Novel Approach to Immunotherapy of Skin Cancer

(2009) M. R. Shurin et al.   CANCER RESEARCH

Melanoma-Specific Memory T Cells Are Functionally Active in Ret Transgenic Mice without Macroscopic Tumors

(2008) V. Umansky et al.   CANCER RESEARCH

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009

(2008) G Kroemer et al.   CELL DEATH AND DIFFERENTIATION

Immunogenic cancer cell death: a key-lock paradigm

(2008) Antoine Tesniere et al.   CURRENT OPINION IN IMMUNOLOGY

Is interleukin-1 a good or bad ‘guy’ in tumor immunobiology and immunotherapy?

(2008) Ron N. Apte et al.   IMMUNOLOGICAL REVIEWS

The immune reaction against allogeneic necrotic cells is reduced in Annexin A5 knock out mice whose macrophages display an anti-inflammatory phenotype

(2008) Benjamin Frey et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

The anticancer immune response: indispensable for therapeutic success?

(2008) Laurence Zitvogel et al.   JOURNAL OF CLINICAL INVESTIGATION

Low-dose Chemotherapeutic Agents Regulate Small Rho GTPase Activity in Dendritic Cells

(2008) Galina V. Shurin et al.   JOURNAL OF IMMUNOTHERAPY